Role of CD20
+
T cells in multiple sclerosis: implications for treatment with ocrelizumab
Neural Regen Res
.
2020 Apr;15(4):663-664.
doi: 10.4103/1673-5374.266913.
Authors
Stefan Gingele
1
,
Thomas Skripuletz
1
,
Roland Jacobs
2
Affiliations
1
Department of Neurology, Hannover Medical School, Hannover, Germany.
2
Department of Clinical Immunology & Rheumatology, Hannover Medical School, Hannover, Germany.
PMID:
31638088
PMCID:
PMC6975146
DOI:
10.4103/1673-5374.266913
No abstract available